Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2016

Open Access 01-02-2016 | Research Article

Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands

Authors: Sek Hung Chau, Aaltje P. D. Jansen, Peter M. van de Ven, Petra Hoogland, Petra J. M. Elders, Jacqueline G. Hugtenburg

Published in: International Journal of Clinical Pharmacy | Issue 1/2016

Login to get access

Abstract

Background Knowledge of drug-related problems (DRPs) identified in the medication of home-dwelling elderly patients with polypharmacy has been based predominantly on medication reviews conducted in research settings rather than in daily practice. Objective To evaluate the prevalence of DRPs identified by means of a clinical medication review (CMR) and the implementation rate of proposed interventions in a large group of older patients with polypharmacy in the daily practice of community pharmacies. Setting 318 Dutch community pharmacies. Method A cross-sectional study based on CMR-data of 3807 older patients (≥65 years) with polypharmacy (≥5 drugs) completed between January and August 2012. Data were extracted from community pharmacists’ databases and entailed: year of birth, gender, dispensing data, number and nature of identified DRPs, consultations performed, proposed and implemented interventions. Main outcome measure Prevalence of DRPs, drug classes involved in overtreatment and undertreatment, and proposed and implemented interventions. Results A median of two DRPs (interquartile range 1–4; mean 3.0) was identified per patient. The DRP-categories overtreatment (25.5 %) and undertreatment (15.9 %) were found most frequently. 46.2 % of the proposed interventions to solve DRPs were implemented as proposed, in 22.4 % of cases, the intervention differed from the proposal. In 31.3 % of cases no intervention was implemented. Conclusion By conducting a CMR community pharmacists identified a median of two DRPs in older patients with polypharmacy. Overtreatment and undertreatment accounted for 41.4 % of the DRPs identified. In dealing with DRPs, pharmacists proposed a variety of interventions of which the majority (69.9 %) was either implemented or led to alternative interventions. A set of explicit criteria should be applied during a CMR to solve and prevent DRPs.
Literature
1.
go back to reference Nederlands Huisartsen Genootschap [Dutch College of General Practitioners]. Multidisciplinaire Richtlijn Polyfarmacie bij ouderen 2012 [Multidisciplinary Directive Polypharmacy in the elderly 2012]. Utrecht: Nederlands Huisartsen Genootschap; 2012. Dutch. Nederlands Huisartsen Genootschap [Dutch College of General Practitioners]. Multidisciplinaire Richtlijn Polyfarmacie bij ouderen 2012 [Multidisciplinary Directive Polypharmacy in the elderly 2012]. Utrecht: Nederlands Huisartsen Genootschap; 2012. Dutch.
4.
go back to reference Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci. 2002;24(4):120–7.CrossRefPubMed Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci. 2002;24(4):120–7.CrossRefPubMed
5.
go back to reference Lowe CJ, Petty DR, Zermansky AG, Raynor DK. Development of a method for clinical medication review by a pharmacist in general practice. Pharm World Sci. 2000;22(4):121–6.CrossRefPubMed Lowe CJ, Petty DR, Zermansky AG, Raynor DK. Development of a method for clinical medication review by a pharmacist in general practice. Pharm World Sci. 2000;22(4):121–6.CrossRefPubMed
7.
go back to reference Kwint HF, Faber A, Gussekloo J, Bouvy ML. The contribution of patient interviews to the identification of drug-related problems in home medication review. J Clin Pharm Ther. 2012;37(6):674–80.CrossRefPubMed Kwint HF, Faber A, Gussekloo J, Bouvy ML. The contribution of patient interviews to the identification of drug-related problems in home medication review. J Clin Pharm Ther. 2012;37(6):674–80.CrossRefPubMed
8.
go back to reference Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30(3):205–11.CrossRefPubMed Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30(3):205–11.CrossRefPubMed
9.
go back to reference Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA, HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890–6.PubMed Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA, HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890–6.PubMed
10.
go back to reference Simonson W, Feinberg JL. Medication-related problems in the elderly: defining the issues and identifying solutions. Drugs Aging. 2005;22(7):559–69.CrossRefPubMed Simonson W, Feinberg JL. Medication-related problems in the elderly: defining the issues and identifying solutions. Drugs Aging. 2005;22(7):559–69.CrossRefPubMed
11.
go back to reference De Smet PAGM, HARM-Wrestling Group. Hospital admissions related to medications and implementing guidelines. Arch Intern Med. 2009;169(8):810–1 (author reply 811).PubMed De Smet PAGM, HARM-Wrestling Group. Hospital admissions related to medications and implementing guidelines. Arch Intern Med. 2009;169(8):810–1 (author reply 811).PubMed
12.
go back to reference Warlé-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PMLA, De Smet PAGM, Dutch HARM-Wrestling Task Force. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force. Drug Saf. 2012;35(3):245–59.CrossRefPubMed Warlé-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PMLA, De Smet PAGM, Dutch HARM-Wrestling Task Force. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force. Drug Saf. 2012;35(3):245–59.CrossRefPubMed
13.
go back to reference Milos V, Rekman E, Bondesson Å, Eriksson T, Jakobsson U, Westerlund T, et al. Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study. Drugs Aging. 2013;30(4):235–46.CrossRefPubMed Milos V, Rekman E, Bondesson Å, Eriksson T, Jakobsson U, Westerlund T, et al. Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study. Drugs Aging. 2013;30(4):235–46.CrossRefPubMed
14.
go back to reference Kwint HF, Faber A, Gussekloo J, Bouvy ML. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: a pragmatic randomized controlled study. Drugs Aging. 2011;28(4):305–14.CrossRefPubMed Kwint HF, Faber A, Gussekloo J, Bouvy ML. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: a pragmatic randomized controlled study. Drugs Aging. 2011;28(4):305–14.CrossRefPubMed
15.
go back to reference Laaksonen R, Duggan C, Bates I. Performance of community pharmacists in providing clinical medication reviews. Ann Pharmacother. 2010;44(7–8):1181–90.CrossRefPubMed Laaksonen R, Duggan C, Bates I. Performance of community pharmacists in providing clinical medication reviews. Ann Pharmacother. 2010;44(7–8):1181–90.CrossRefPubMed
16.
go back to reference Kwint HF, Faber A, Gussekloo J, Bouvy ML. Completeness of medication reviews provided by community pharmacists. J Clin Pharm Ther. 2014;39(3):248–52.CrossRefPubMed Kwint HF, Faber A, Gussekloo J, Bouvy ML. Completeness of medication reviews provided by community pharmacists. J Clin Pharm Ther. 2014;39(3):248–52.CrossRefPubMed
17.
go back to reference Stafford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C, et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci. 2009;31(2):216–23.CrossRefPubMed Stafford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C, et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci. 2009;31(2):216–23.CrossRefPubMed
18.
go back to reference Elliott RA, Woodward MC. Medication-related problems in patients referred to aged care and memory clinics at a tertiary care hospital. Australas J Ageing. 2011;30(3):124–9.CrossRefPubMed Elliott RA, Woodward MC. Medication-related problems in patients referred to aged care and memory clinics at a tertiary care hospital. Australas J Ageing. 2011;30(3):124–9.CrossRefPubMed
19.
go back to reference Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ. 2003;169(1):17–22.PubMedPubMedCentral Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ. 2003;169(1):17–22.PubMedPubMedCentral
20.
go back to reference Vinks THAM, Egberts TCG, de Lange TM, de Koning FHP. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging. 2009;26(2):123–33.CrossRefPubMed Vinks THAM, Egberts TCG, de Lange TM, de Koning FHP. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging. 2009;26(2):123–33.CrossRefPubMed
21.
go back to reference Denneboom W, Dautzenberg MGH, Grol R, De Smet PAGM. Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches. Br J Gen Pract. 2007;57(542):723–31.PubMedPubMedCentral Denneboom W, Dautzenberg MGH, Grol R, De Smet PAGM. Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches. Br J Gen Pract. 2007;57(542):723–31.PubMedPubMedCentral
22.
go back to reference Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care—the POLYMED randomised controlled trial. Age Ageing. 2007;36(3):292–7.CrossRefPubMed Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care—the POLYMED randomised controlled trial. Age Ageing. 2007;36(3):292–7.CrossRefPubMed
23.
go back to reference Grymonpre RE, Williamson DA, Montgomery PR. Impact of a pharmaceutical care model for non-institutionalised elderly: results of a randomised, controlled trial. Int J Pharm Pract. 2001;9(4):235–41.CrossRef Grymonpre RE, Williamson DA, Montgomery PR. Impact of a pharmaceutical care model for non-institutionalised elderly: results of a randomised, controlled trial. Int J Pharm Pract. 2001;9(4):235–41.CrossRef
24.
go back to reference Allard J, Hébert R, Rioux M, Asselin J, Voyer L. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ. 2001;164(9):1291–6.PubMedPubMedCentral Allard J, Hébert R, Rioux M, Asselin J, Voyer L. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ. 2001;164(9):1291–6.PubMedPubMedCentral
25.
go back to reference Ministerie van Volksgezondheid, Welzijn en Sport [Ministry of Health, Welfare and Sport]. Wet van 16 juni 2005, houdende regeling van een sociale verzekering voor geneeskundige zorg ten behoeve van de gehele bevolking (Zorgverzekeringswet) [Regulation on the Social Insurance for Medical Care for the Entire Population (Health Insurance Act)]. Staatsblad van het Koninkrijk der Nederlanden 2005;358. Dutch. Ministerie van Volksgezondheid, Welzijn en Sport [Ministry of Health, Welfare and Sport]. Wet van 16 juni 2005, houdende regeling van een sociale verzekering voor geneeskundige zorg ten behoeve van de gehele bevolking (Zorgverzekeringswet) [Regulation on the Social Insurance for Medical Care for the Entire Population (Health Insurance Act)]. Staatsblad van het Koninkrijk der Nederlanden 2005;358. Dutch.
26.
go back to reference Monster TBM, Janssen WMT, de Jong PE, de Jong-van den Berg LTW, PREVEND Study Group Prevention of REnal and Vascular ENT Stage Disease. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf. 2002;11(5):379–84.CrossRefPubMed Monster TBM, Janssen WMT, de Jong PE, de Jong-van den Berg LTW, PREVEND Study Group Prevention of REnal and Vascular ENT Stage Disease. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf. 2002;11(5):379–84.CrossRefPubMed
27.
go back to reference Buurma H, Bouvy ML, De Smet PAGM, Floor-Schreudering A, Leufkens HGM, Egberts ACG. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther. 2008;33(1):17–23.CrossRefPubMed Buurma H, Bouvy ML, De Smet PAGM, Floor-Schreudering A, Leufkens HGM, Egberts ACG. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther. 2008;33(1):17–23.CrossRefPubMed
28.
go back to reference Ministerie van Volksgezondheid, Welzijn en Sport [Ministry of Health, Welfare and Sport]. Regeling van de Minister van Volksgezondheid, Welzijn en Sport van 2 juli 2013 (kenmerk 125176-105466-GMT), houdende wijziging van de Regeling Geneesmiddelenwet betreffende de uitwisseling van laboratoriumgegevens en de vermelding van de redden van voorschrijven. [Amendment on the Medicines Act on the exchange of laboratory data and stating the reason for prescribing.] Staatscourant 2013;18918. Dutch. Ministerie van Volksgezondheid, Welzijn en Sport [Ministry of Health, Welfare and Sport]. Regeling van de Minister van Volksgezondheid, Welzijn en Sport van 2 juli 2013 (kenmerk 125176-105466-GMT), houdende wijziging van de Regeling Geneesmiddelenwet betreffende de uitwisseling van laboratoriumgegevens en de vermelding van de redden van voorschrijven. [Amendment on the Medicines Act on the exchange of laboratory data and stating the reason for prescribing.] Staatscourant 2013;18918. Dutch.
29.
go back to reference Keijsers CJPW, van Doorn ABD, van Kalles A, de Wildt DJ, Brouwers JRBJ, van de Kamp HJ, et al. Structured pharmaceutical analysis of the systematic tool to reduce inappropriate prescribing is an effective method for final-year medical students to improve polypharmacy skills: a randomized controlled trial. J Am Geriatr Soc. 2014;62(7):1353–9.CrossRefPubMed Keijsers CJPW, van Doorn ABD, van Kalles A, de Wildt DJ, Brouwers JRBJ, van de Kamp HJ, et al. Structured pharmaceutical analysis of the systematic tool to reduce inappropriate prescribing is an effective method for final-year medical students to improve polypharmacy skills: a randomized controlled trial. J Am Geriatr Soc. 2014;62(7):1353–9.CrossRefPubMed
30.
go back to reference Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738–47.CrossRefPubMedPubMedCentral Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738–47.CrossRefPubMedPubMedCentral
31.
go back to reference Mast R, Ahmad A, Hoogenboom SC, Cambach W, Elders PJ, Nijpels G, Hugtenburg JG. Amsterdam tool for clinical medication review: development and testing of a comprehensive tool for pharmacists and general practitioners. BMC Res Notes. 2015;8:642. Mast R, Ahmad A, Hoogenboom SC, Cambach W, Elders PJ, Nijpels G, Hugtenburg JG. Amsterdam tool for clinical medication review: development and testing of a comprehensive tool for pharmacists and general practitioners. BMC Res Notes. 2015;8:642.
32.
go back to reference Lee TJ, Fennerty MB, Howden CW. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease? Aliment Pharmacol Ther. 2004;20(11–12):1241–51.CrossRefPubMed Lee TJ, Fennerty MB, Howden CW. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease? Aliment Pharmacol Ther. 2004;20(11–12):1241–51.CrossRefPubMed
34.
go back to reference Kwint H-F, Bermingham L, Faber A, Gussekloo J, Bouvy ML. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs Aging. 2013;30(2):91–102.CrossRefPubMed Kwint H-F, Bermingham L, Faber A, Gussekloo J, Bouvy ML. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs Aging. 2013;30(2):91–102.CrossRefPubMed
35.
go back to reference KNMP [Royal Dutch Pharmacists Association]. KNMP-richtlijn Zorg voor patiënten met geneesmiddelen in een geïndividualiseerde distributievorm [KNMP-directive Care for patients with drugs in a multidose drug dispensing system]; 2013. Dutch. KNMP [Royal Dutch Pharmacists Association]. KNMP-richtlijn Zorg voor patiënten met geneesmiddelen in een geïndividualiseerde distributievorm [KNMP-directive Care for patients with drugs in a multidose drug dispensing system]; 2013. Dutch.
Metadata
Title
Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands
Authors
Sek Hung Chau
Aaltje P. D. Jansen
Peter M. van de Ven
Petra Hoogland
Petra J. M. Elders
Jacqueline G. Hugtenburg
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0199-8

Other articles of this Issue 1/2016

International Journal of Clinical Pharmacy 1/2016 Go to the issue